-
UTI Healthcare Fund Regular Plan Growth
Equity healthcare
Overview ( as on 06/02/26 )
NAV
₹276.06
Last change
₹-0.46 -0.0%
Fund Size (AUM)
1101.63 Cr
Performance
14.27% (5Y)
Fund Details
UTI Healthcare Fund Regular Plan Growth
as of 06/02/26
AUM
1101.63 Cr
Expense Ratio
2.27 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01695
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | -0.52% | 24.45% | 14.27% |
| BSE Healthcare TR INR | -1.09% | 22.5% | 14.92% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
9.07% |
Ajanta Pharma Ltd |
7.3% |
Lupin Ltd |
6.02% |
Glenmark Pharmaceuticals Ltd |
4.2% |
Gland Pharma Ltd |
3.98% |
Alkem Laboratories Ltd |
3.66% |
Apollo Hospitals Enterprise Ltd |
3.5% |
Dr Reddy's Laboratories Ltd |
3.46% |
Procter & Gamble Health Ltd |
3.02% |
Jupiter Life Line Hospitals Ltd |
2.91% |
Sector Allocation
Healthcare |
98.84% |
Basic Materials |
1.16% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Growth
Equity healthcare-
Returns
-
16.49% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
15.84% (5Y)
-
-
UTI Healthcare Growth
Equity healthcare-
Returns
-
14.27% (5Y)
-
-
UTI Healthcare IDCW-P
Equity healthcare-
Returns
-
14.27% (5Y)
-
-
UTI Healthcare IDCW-R
Equity healthcare-
Returns
-
14.27% (5Y)
-
-
SBI Healthcare Opportunities Growth
Equity healthcare-
Returns
-
15.16% (5Y)
-
